DLL3

Assets acting on this target.

Class
CAR-T

By indication

Related mechanisms

DLL3 drugs compared

3 drugs, stage by indication
3 drugs acting on DLL3: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
SHR-4849Jiangsu Hengrui Pharmaceuticalsantibody-drug conjugatePhase 2Phase 1 in Advanced Solid Tumors
DJI136Novartiscell therapy (CAR-T)Phase 1/2Phase 1/2 in Small Cell Lung Cancer
225Ac-ETN029Novartisradioligand therapy (actinium-225)Stage not recordedNot recorded

← all mechanisms